Greenville Health System Cancer Institute-Spartanburg is a clinical research site located in Spartanburg, South Carolina, United States 29307.
Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.
Greenville Health System Cancer Institute-Spartanburg has participated in 71 clinical trials with 10 currently active.
Therapeutic areas: Chemotherapeutic Agent Toxicity, Neuropathy, Neurotoxicity Syndrome.
Sponsors: Alliance for Clinical Trials in Oncology, Gynecologic Oncology Group, ECOG-ACRIN Cancer Research Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in South Carolina · View every site in Spartanburg
Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Greenville Health System Cancer Institute-Spartanburg has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Greenville Health System Cancer Institute-Spartanburg has 71 clinical trials on record, with 10 currently active. Their work covers Chemotherapeutic Agent Toxicity, Neuropathy, Neurotoxicity Syndrome.
Greenville Health System Cancer Institute-Spartanburg has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.